Clinical indications for the use of cardiac MRI. by the SIRM Study Group on Cardiac Imaging;Indicazioni cliniche per l'utilizzo della cardio RM. A cura del Gruppo di lavoro della Sezione di Cardio-Radiologia della SIRM

Radiologia Medica

Volumn 118, Issue 5, 2013, Pages 752-798

  Di Cesare, E ^a   Cademartiri, F ^b,s   Carbone, I ^c   Carriero, A ^d   Centonze, M ^e   De Cobelli, F ^f   De Rosa, R ^g   Di Renzi, P ^h   Esposito, A ^f   Faletti, R ⁱ   Fattori, R ^j   Francone, M ^c   Giovagnoni, A ^k   La Grutta, L ^l   Ligabue, G ^m   Lovato, L ^j   Marano, R ⁿ   Midiri, M ^l   Romagnoli, A ^o   Russo, V ^j   Sardanelli, F ^p   Natale, L ⁿ   Bogaert, J ^q   De Roos, A ^r   more..

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Giovanni XXIII Hospital   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^e Dipartimento di Radiodiagnostica   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g San Gennaro Hospital   (Italy)

^h FATEBENEFRATELLI HOSPITAL   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^l UNIVERSITY OF PALERMO   (Italy)

^m UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁿ CATHOLIC UNIVERSITY   (Italy)

^o TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^p UNIVERSITY OF MILAN   (Italy)

^q UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^r LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^s ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Heart; Magnetic resonance

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; ITALY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING;

EID: 84884765089     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-012-0899-2     Document Type: Article

References (196)

1. Pennell D, Sechtem U, Higgins CC et al (2004) Clinical indications for cardiovascular magnetic resonance: consensus panel report. Eur Heart J 25:1940-1965
2. Hendel RC, Patel MR, Kramer CMN et al (2006) ACCF/ACR/SCCT/ SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol 48:1475-1497
3. Mark DB, Berman DS, Budoff MJ et al (2010) ACCF/ACR/AHA/NASCI/ SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 23:2663-2699
4. International Commission on Radiological Protection (2007) The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP 37:2-4
5. Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078-2086
6. Kim RJ, de Roos A, Fleck E et al; Society of Cardiovascular Magnetic Resonance (SCMR) Clinical Practice Committee (2007) Guidelines for training in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson 9:3-4
7. Sarikouch S, Schaeffler R, Körperich H et al (2009) Cardiovascular magnetic resonance imaging for intensive care infants: safe and effective? Pediatric Cardiol 30:146-152
8. Odegard KC, Dinardo JA, Tsai-Goodman B et al (2004) Anaesthesia considerations for cardiac MRI in infants and small children. Paediatr Anaesth 14:471-476
9. Lovato L, Giardini A, La Palombara C et al (2007) Role and effectiveness of cardiovascular magnetic resonance in the diagnosis, preoperative evaluation and follow-up of patients with congenital heart diseases. Radiol Med 112:660-680
10. De Roos A, Roest AA (2000) Evaluation of congenital heart disease by magnetic resonance imaging. Eur Radiol 10:2-6
11. Yamamura J, Schnackenburg, B Kooijmann H et al (2009) High resolution MR imaging of the fetal heart with cardiac triggering: a feasibility study in the sheep fetus. Eur Radiol 19:2383-2390
12. Lapierre C, Déry J, Guérin R et al (2010) Segmental approach to imaging of congenital heart disease. Radiographics 30:397-411
13. Hong YK, Park YW, Ryu SJ et al (2000) Efficacy of MRI in complicated congenital heart disease with visceral heterotaxy syndrome. J Comput Assist Tomogr 24:671-682
14. Rahmani N, White CS (2008) MR imaging of thoracic veins. Magn Reson Imaging Clin N Am 16:249-262
15. Taylor AM, Stables RH, Poole-Wilson PA et al (1999) Definitive clinical assessment of atrial septal defect by magnetic resonance imaging. J Cardiovasc Magn Reson 1:43-7
16. Piaw CS, Kiam OT, Rapaee A et al (2006) Use of non-invasive phase contrast magnetic resonance imaging for estimation of atrial septal defect size and morphology: a comparison with transesophageal echo. Cardiovasc Intervent Radiol 29:230-234
17. Debl K, Djavidani B, Buchner S et al (2009) Quantification of left-to-right shunting in adult congenital heart disease: phase-contrast cine MRI compared with invasive oximetry. Br J Radiol 82:386-391
18. Gulati G, Hoey ET, Gopalan D et al (2010) Sinus venosus atrial septal defect in adults: utility of cardiovascular MRI in resolving this diagnostic dilemma. Heart Lung Circ 19:615-619
19. Riesenkampff EM, Schmitt B, Schnackenburg B et al (2009) Partial anomalous pulmonary venous drainage in young pediatric patients: the role of magnetic resonance imaging. Pediatr Cardiol 30:458-464
20. Festa P, Ait-Ali L, Cerillo AG et al (2006) Magnetic resonance imaging is the diagnostic tool of choice in the preoperative evaluation of patients with partial anomalous pulmonary venous return. Int J Cardiovas Imaging 22: 685-693
21. Hamilton-Craig C, Sestito A, Natale L et al (2011) Contrast transoesophageal echocardiography remains superior to contrast-enhanced cardiac magnetic resonance imaging for the diagnosis of patent foramen ovale. Eur J Echocardiogr 12:222-227
22. Yoo SJ, Kim YM, Choe YH (1999) Magnetic resonance imaging of complex congenital heart disease. Int J Card Imaging 15:151-160
23. Didier D, Higgins CB (1986) Identification and localization of ventricular septal defect by gated magnetic resonance imaging. Am J Cardiol 57:1363-1368
24. Dorfman Al, Geva T (2006) Magnetic resonance imaging evaluation of congenital heart disease: conotruncal anomalies. J Cardiovasc Magn Reson 8:645-659
25. Srinivas B, Patnaik AN Rao DS (2011) Gadolinium-enhanced threedimensional magnetic resonance angiographic assessment of the pulmonary artery anatomy in cyanotic congenital heart disease with pulmonary stenosis or atresia: comparison with cineangiography. Pediatr Cardiol 32:737-742
26. Geva T, Greil GF, Marshall AC et al (2002) Gadolinium-enhanced 3-dimensional magnetic resonance angiography of pulmonary blood supply in patients with complex pulmonary stenosis or atresia: comparison with X-ray angiography. Circulation 106:473-478
27. Margossian R, Schwartz ML, Prakash A et al (2009) Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Multicenter Fontan Cross-Sectional Study). Am J Cardiol 104:419-428
28. Yalonetsky S, Tobler D, Greutmann M et al (2011) Cardiac magnetic resonance imaging and the assessment of Ebstein anomaly in adults. Am J Cardiol 107:767-773
29. Kallenberger CJ (2010) Aortic arch malformations. Pediatr Radiol 40:876-884
30. Bank ER, Aisen AM, Rocchini AP, Hernandes RJ (1987) Coarctation of the aorta in children undergoing angioplasty: pretreatment and posttreatment MR imaging. Radiology 162:235-240
31. Hom J, Ordovas K, ReddY GO (2008) Velocity-encoded cine MR imaging in aortic coarctation: functional assessment of hemodynamic events. Radiographics 28:407-416
32. Rosenthal E, Bell A (2010) Optimal imaging after coarctation stenting. Heart 96:1169-1171
33. Schmidt M, Theissen P, Deutsch HJ et al (1999) Magnetic resonance imaging of ductus arteriosus Botalli apertus in adulthood. Int J Cardiol 68:225-229
34. Boechat MI, Ratib O, Williams PL et al (2005) Cardiac MR imaging and MR angiography for assessment of complex tetralogy of Fallot and pulmonary atresia. Radiographics 25:1535-1546
35. Jacobstein MD, Fletcher BD, Nelson AD et al (1984) Magnetic resonance imaging: evaluation of palliative systemic-pulmonary artery shunts. Circulation 70:650-656
36. Kilner PJ, Balossino R, Dubini G et al (2009) Pulmonary regurgitation: the effects of varying pulmonary artery compliance, and of increased resistance proximal or distal to the compliance. Int J Cardiol 133:157-166
37. Grothues F, Moon JC, Bellenger NG et al (2004) Interstudy reproducibility of right ventricular volumes, function and mass with cardiovascular magnetic resonance. Am Heart J 147:218-223
38. Babu-Narayan SV, Kilner PJ, Li W et al (2006) Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 113:405-413
39. Davlouros PA, Kilner PJ, Hornung TS et al (2002) Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol 40:2044-2052
40. Therrien J, Provost Y, Merchant N et al (2005) Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol 95:779-782
41. Taylor AM, Dymarkowski S, Hamaekers P et al (2005) MR coronary angiography and late-enhancement myocardial MR in children who underwent arterial switch surgery for trasposition of great arteries. Radiology 234:542-547
42. Grosse-Wortmann L, Al-Otay A, Yoo SJ (2009) Aortopulmonary collaterals after bidirectional cavopulmonary connection or Fontan completion: quantification with MRI. Circ Cardiovasc Imaging 2:219-225
43. Taylor AM, Thorne SA, Rubens MB et al (2000) Coronary artery imaging in grown-up congenital heart disease: complementary role of MR and X-ray coronary angiography. Circulation 101:1670-1678
44. Tangcharoen T, Bell A, Hegda S et al (2011) Detection of coronary artery anomalies in infants and young children with congenital heart disease by using MR imaging. Radiology 259:240-247
45. Bluemke DA, Achenbach S, Budoff M et al (2008) Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation 118:586-606
46. Russo V, Renzulli M, Buttazzi K, Fattori R (2006) Acquired diseases of the thoracic aorta: role of MRI and MRA. Eur Radiol 16:852-865
47. Kranokpiraksa P, Kaufman JA (2008) Follow-up of endovascular aneurysm repair: plain radiography, ultrasound, CT/CT angiography, MR imaging/MR angiography, or what? J Vasc Interv Radiol 19:S27-S36
48. Moore AG, Eagle KA, Bruckman D et al (2002) Choice of computed tomography, transesophageal echocardiography magnetic resonance imaging and aorthography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). Am J Cardiol 89:1235-1238
49. Murray JG, Manisali M, Flamm SD et al (1997) Intramural hematoma of the thoracic aorta: MR imaging findings and their prognostic implications. Radiology 204:349-355
50. Kawamoto S, Bluemke DA, Traill TA, Zerhouni EA (1997) Thoracoabdominal aorta in Marfan syndrome: MR imaging findings of progression of vasculopathy after surgical repair. Radiology 203:727-732
51. Fattori R, Nienaber CA (1999) MRI of acute and chronic aortic pathology: preoperative and postoperative evaluation. J Magn Reson Imaging 10:741-750
52. Choe YH, Kim DK, Koh EM et al (1999) Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 10:751-757
53. Bley TA, Uhl M, Venhoff N et al (2007) 3-T MRI reveals cranial and thoracic inflammatory changes in giant cell arteritis. Clin Rheumatol 26:448-450
54. Balu N, Wang J, Dong L et al (2009) Current techniques for MR imaging of atherosclerosis. Top Magn Reson Imaging 20:203-215
55. Momiyama Y, Fayad ZA (2007) Aortic plaque imaging and monitoring atherosclerotic plaque interventions. Top Magn Reson Imaging 18:349-355
56. Makowsky MR, Wiethoff AJ, Blume U et al (2011) Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med 17:383-388
57. Oudkerk M, van Beek EJ, Wielopolski P et al (2002) Comparison of contrastenhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 359:1643-1647
58. Fink C, Ley S, Schoenberg S et al (2007) Magnetic resonance imaging of acute pulmonary embolism. Eur Radiol 17:2546-2553
59. Iino M, Dymarkowski S, Chaothawee L et al (2008) Time course of reversed cardiac remodelling after pulmonary endoarterectomy in patients with chronic pulmonary thromboembolism. Eur Radiol 18:792-799
60. Lorenz CH, Walker ES, Morgan VL et al (1999) Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1:7-21
61. Bellenger NG, Burgess M, Ray SG et al (2000) Comparison of left ventricular ejection fraction and volumes in heart failure by twodimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable. Eur Heart J 21:1387-1396
62. Mogelvang J, Lindvig K, Sondergaard L et al (1993) Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI. Clin Physiol 13:587-597
63. Bellenger NG, Davies LC, Francis JM et al (2000) Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2:271-278
64. Azhari H, Sideman S, Weiss JL et al (1990) Three-dimensional mapping of acute ischemic regions using MRI: wall thickening versus motion analysis. Am J Physiol 259:H1492-1503
65. Lima JA, Jeremy R, Guier W et al (1993) Accurate systolic wall thickening by nuclear magnetic resonance imaging with tissue tagging: correlation with sonomicrometers in normal and ischemic myocardium. J Am Coll Cardiol 21:1741-1751
66. Nagel E, Lorenz C, Baer F et al (2001) Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 3:267-281
67. Nagel E, Lehmkuhl HB, Bocksch W et al (1999) Noninvasive diagnosis of ischemia induced wall motion abnormalities with the use of high dose dobutamine stress MRI. Comparison with dobutamine stress echocardiography. Circulation 99:763-770
68. Schwitter J, Nanz D, Kneifel S et al (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230-2235
69. Al-Saadi N, Nagel E, Gross M et al (2000) Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 101:1379-1383
70. Schwitter J, Wacker CM, van Rossum AC et al (2008) MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 29:480-489
71. Kim RJ, Chen EL, Lima JA, Judd RM (1996) Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94:3318-3326
72. Wagner A, Mahrholdt H, Holly TA et al (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374-379
73. Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-1453
74. Wu KC, Kim RJ, Bluemke DA et al (1998) Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 32:1756-1764
75. Ganame J, Messalli G, Dymarkowski S et al (2009) Impact of myocardial hemorrage on left ventricular function and remodelling in patients with reperfused myocardial infarction. Eur Heart J 30:1440-1449
76. Masci PG, Francone M, Desmet W et al (2010) Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation 122:1405-1412
77. Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J (2006) Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol 16:569-574
78. Nagata M, Kato S, Kitagawa K et al (2011) Diagnostic accuracy of 1.5-T unenhanced whole-heart coronary MR angiography performed with 32-channel coils: initial single-center experience. Radiology 259:384-392
79. McCrohon JA, Moon JC, Prasad SK et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54-59
80. Cummings KW, Bhalla S, Javidan-Nejad C et al (2009) A patternbased approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics 29:89-103
81. Marsan NA, Westenberg JJ, Ypenburg C et al (2009) Magnetic resonance imaging and response to cardiac resynchronization therapy: relative merits of left ventricular dyssynchrony and scar tissue. Eur Heart J 30:2360-2367
82. Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977-1985
83. Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92:785-789
84. Maron BJ (2003) Sudden death in young athletes. N Engl J Med 349:1064-1075
85. Maron BJ, McKenna WJ, Danielson GK et al; Task Force on Clinical Expert Consensus Documents; American College of Cardiology; Committee for Practice Guidelines; European Society of Cardiology (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687-1713
86. Chun EJ, Choi SI, Jin KN et al (2010) Hypertrophic cardiomyopathy assessment with MR imaging and multidetector CT. Radiographics 30:1309-1328
87. Nagueh SF, Mahmarian JJ (2006) Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 48:2410-2422
88. Petersen SE, Selvanayagam JB, Francis JM et al (2005) Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 7:551-558
89. Maron MS, Olivotto I, Maron BJ et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866-875
90. Hansen MW, Merchant N (2007) MRI of hypertrophic cardiomyopathy: part II. Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol 189:1344-1352
91. Hansen MW, Merchant N (2007) MRI of hypertrophic cardiomyopathy. Differential diagnosis, risk stratification, and posttreatment MRI appearances. Am J Roentgenol 189:1344-1352
92. Strijack B, Ariyarajah V, Soni R et al (2008) Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson 10:58
93. Giorgi B, Mollet NR, Dymarkowski S et al (2003) Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. Radiology 228:417-424
94. Cheng H, Zhao S, Jiang S et al (2011) The relative atrial volume ratio and late gadolinium enhancement provide additive information to differentiate constrictive pericarditis from restrictive cardiomyopathy. J Cardiovasc Magn Reson 13:15
95. Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155-164
96. Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186-193
97. Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683-1690
98. Smedema JP, Snoep G, van Kroonenburgh MP et al (2005) The additional value of gadoliniumenhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005 128:1629-1637
99. De Cobelli F, Esposito A, Belloni E et al (2009) Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy. AJR Am J Roentgenol 192:W97-102
100. Salemi VM, Rochitte CE, Shiozaki AA et al (2011) Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging 4:304-311
101. Kondur AK, Li T, Vaitkevicius P, Afonso L (2009) Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2and review of the literature. Clin Cardiol 32:E55-E59
102. Petersen SE, Selvanayagam JB, Wiesmann F (2005) Left ventricular noncompaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 46:101-105
103. Jain A, Tandri H, Calkins H, Bluemke DA (2008) Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson 10:32
104. Markus FI, McKenna Wj, Sherril D et al (2010) Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 121:1533-1541
105. Ramazzotti A, Pepe A, Positano V et al (2009) Multicenter validation of the magnetic resonance T2technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 30:62-68
106. Di Cesare E (2003) MRI assessment of right ventricular dysplasia. Eur Rad 13:1387-1393
107. Mavrogeni SI, Markussis V, Kaklamanis L et al (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 75:241-247
108. Belloni E, De Cobelli F, Esposito A et al (2008) MRI of cardiomyopathy. Am J Roentgenol 191:1702-1710
109. Smedema JP, Snoep G, van Kroonenburgh MPG et al (2005) Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 45:1683-1690
110. Vignaux O (2005) Cardiac sarcoidosis: spectrum of MRI features. Am J Roentgenol 184:249-254
111. Ichinose A, Otani H, Oikawa M et al (2008) MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. Am J Roentgenol 191:862-869
112. Matoh F, Satoh H, Shiraki K et al (2008) The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients in cardiac sarcoidosis. J Cardiol 51:179-188
113. Moon JC, Sachdev B, Elkington AG et al (2003) Gadolinium enhanced cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. Eur Heart J 24:2151-2155
114. Sachdev B, Takenaka T, Teraguchi H et al (2002) Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105:1407-1411
115. Moon JC, Sheppard M, Reed E, Lee P. Elliot PM, Pennel DJ (2006) The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J. Cardiovasc Magnetic Reson 8:479-482
116. Hughes DA, Elliott PM, Shah J et al (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebocontrolled clinical trial of agalsidase alfa. Heart 94:153-158
117. Ruberg FL, Appelbaum E, Davidoff R et al (2009) Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol 103:544-549
118. Cooper LT Jr (2009): Myocarditis. N Engl J Med 360:1526-1538
119. Friedrich MG, Sechtem U, Schulz-Menger J et al; International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 53:1475-1487
120. Cocker M, Friedrich MG (2010) Cardiovascular magnetic resonance of myocarditis. Curr Cardiol Rep 12:82-89
121. Feldman AM, McNamara D (2000) Medical progress: myocarditis. N Engl J Med 343:1388-1398
122. Magnani JW, Dec GW (2006) Myocarditis: current trends in diagnosis and treatment. Circulation 113:876-890
123. Francone M, Carbone I, Agati L et al (2011) Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease. Radiol Med 116:32-46
124. Yelgec NS, Dymarkowski S, Ganame J, Bogaert J (2007) Value of MRI in patients with clinical suspicion of acute myocarditis. Eur Radiol 17:2211-2217
125. Abdel-Aty H, Boyé P, Zagrosek A et al (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815-1822
126. Butler CR, Thompson R, Haykowsky M et al (2009) Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson 11:7
127. Burke AP, Virmani R (1996) Tumors of the heart and great vessels. In: Burke AP, Virmani R (eds) Atlas of Tumor Pathology 3rd series, Vol 16. Armed Forces Institute of Pathology, Washington, DC
128. Sun JP, Asher CR, Yang SX et al (2001) Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation 103:2687-2693
129. Wintersperger BJ, Becker CR, Gulbins H et al (2000) Tumors of the cardiac valves: imaging findings in magnetic resonance imaging, electron beam computed tomography, and echocardiography. Eur Radiol 10:443-449
130. Bruna J, Lockwood M (1998) Primary heart angiosarcoma detected by computed tomography and resonance magnetic imaging. Eur Radiol 8:66-68
131. Dawson WB, Mayo JR, Muller NL (1990) Computed tomography of cardiac and pericardial tumors. Can Assoc Radiol J 41:270-275
132. Yared K, Baggish AL, Picard MH et al (2010) Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging 3:650-660
133. Bogaert J, Francone M (2009) Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson 11:14
134. Francone M, Dymarkowski S, Kalantzi M, Bogaert J (2005) Magnetic resonance imaging in the evaluation of the pericardium. A pictorial essay. Radiol Med 109:64-74
135. Francone M, Dymarkowski S, Kalantzi M et al (2006) Assessment of ventricular coupling with realtime cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 16:944-951
136. Francone M, Dymarkowski S, Kalantzi M, Bogaert J (2005) Realtime cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging 21:305-309
137. Talreja DR, Edwards WD, Danielson GK et al (2003) Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation 108:1852-1857
138. Bonow RO, Carabello BA, Kanu C et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ America Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 48:e1
139. Didier D, Ratib O, Lerch R, Friedli B (2000) Detection an quantification of valvular heart disease with dynamic cardiac MR imaging. Radiographics 20:1279-1299
140. Friedrich M, Schulz-Menger J, Dietz R (2004) Magnetic resonance to assess the aortic valve area in aortic stenosis. J Am Coll Cardiol 43:2148
141. Gelfand EV, Hughes S, Hauser TH et al (2006) Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 8:503
142. Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666
143. Pappone C, Rosanio S, Oreto G et al (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619-2628
144. Kato R, Lickfett L, Meininger G et al (2003) Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation. Circulation 107:2004-2010
145. Marom EM, Herndon JE, Kim YH, McAdams HP (2004) Variations in pulmonary
146. Benini K, Marini M, Del Greco M et al (2008) Role of multidetector computed tomography in the anatomical definition of the left atrium-pulmonary vein complex in patients with atrial fibrillation. Personal experience and pictorial assay. Radiol Med 113:779-798
147. Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100-1105
148. Ghaye B, Szapiro D, Dacher JN et al (2003) Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging. Radiographics 23:S19-S33
149. Schwartzman D, Lacomis J, Wigginton G (2003) Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol 41:1349-1357
150. Therkelsen SK, Groenning BA, Svendsen JH, Jensen GB (2005) Atrial and ventricular volume and function in persistent and permanent atrial fibrillation, a magnetic resonance imaging study. J Cardiovasc Magn Reson 7:465-473
151. Francois CJ, Tuite D, Deshpande V et al (2009) Pulmonary vein imaging with unenhanced three-dimensional balanced steady-state free precession MR angiography: initial clinical evaluation. Radiology 250:932-939
152. Mohrs OK, Nowak B, Petersen SE et al (2006) Thrombus detection in the left atrial appendage using contrastenhanced MRI: a pilot study. AJR Am J Roentgenol 186:198-205
153. Dill T, Neumann T, Ekinci O et al (2003) Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrastenhanced three-dimensional magnetic resonance imaging. Circulation 107:845-850
154. Bertaglia E, Brandolino G, Zoppo F et al (2008) Integration of threedimensional left atrial magnetic resonance images into a real-time electroanatomic mapping system: validation of a registration method. Pacing Clin Electrophysiol 31:273-282
155. Kettering K, Greil GF, Fenchel M et al (2009) Catheter ablation of atrial fibrillation using the Navx-/ Ensite-system and a CT-/MRI-guided approach. Clin Res Cardiol 98:285-296
156. Bertaglia E, Bella PD, Tondo C et al (2009) Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace 11:1004-1010
157. Caponi D, Corleto A, Scaglione M et al (2010) Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace 12:1098-1104
158. McGann CJ, Kholmovski EG, Oakes RS et al (2008) New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol 52:1263-1271
159. Badger TJ, Adjei-Poku YA, Marrouche NF (2009) MRI in cardiac electrophysiology: the emerging role of delayed-enhancement MRI in atrial fibrillation ablation. Future Cardiol 5:63-70
160. Peters DC, Wylie JV, Hauser TH et al (2009) Recurrence of atrial fibrillation correlates with the extent of post-procedural late gadolinium enhancement: a pilot study. JACC Cardiovasc Imaging 2:308-316
161. Oakes RS, Badger TJ, Kholmovski EG et al (2009) Detection and quantification of left atrial structural remodeling with delayedenhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119:1758-1767
162. Meisel E, Pfeiffer D, Engelmann L et al (2001) Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation 104:442-447
163. Cademartiri F, Marano R, Luccichenti G et al (2004) Normal anatomy of the vessels of the heart with 16-row multislice computed tomography. Radiol Med 107:11-21
164. Daubert JC, Ritter P, Le Breton H et al (1998) Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol 21:239-245
165. Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845-1853
166. Nezafat R, Han Y, Peters DC et al (2007) Coronary magnetic resonance vein imaging: imaging contrast, sequence, and timing. Magn Reson Med 58:1196-1206
167. Rasche V, Binner L, Cavagna F et al (2007) Whole-heart coronary vein imaging: a comparison between non-contrast-agent- and contrastagent- enhanced visualization of the coronary venous system. Magn Reson Med 57:1019-1026
168. Chiribiri A, Kelle S, Götze S et al (2008) Visualization of the cardiac venous system using cardiac magnetic resonance. Am J Cardiol 1101:407-412
169. Younger JF, Plein S, Crean A et al (2009) Visualization of coronary venous anatomy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 11:26
170. Malloy CR, Jones JG, Jeffrey FM et al (1996) Contribution of various substrates to total citric acid cycle flux and anaplerosis as determined by 13C isotopomer analysis and O2 consumption in the heart. MAGMA 4:35-46
171. Schroeder MA, Atherton HJ, Ball DR et al (2009) Real-time assessment of Krebs cycle metabolism using hyperpolarized 13C magnetic resonance spectroscopy. FASEB J 23:2529-2538
172. Bottomley PA, Weiss RG (1998) Non-invasive magnetic-resonance detection of creatine depletion in nonviable infarcted myocardium. Lancet 351:714-718
173. Nakae I, Mitsunami K, Matsuo S et al (2004) Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy. Magn Reson Med Sci 3:19-25
174. Nakae I, Mitsunami K, Omura T et al (2003) Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 42:1587-1593
175. Sharma S, Adrogue JV, Golfman L et al (2004) Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18:1692-1700
176. McGavock JM, Lingvay I, Zib I et al (2007) Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 116:1170-1175
177. Malavazos AE, Di Leo G, Secchi F et al (2010) Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 105:1831-1835
178. Bottomley PA (1985) Noninvasive study of high-energy phosphate metabolism in human heart by depthresolved 31P NMR spectroscopy. Science 229:769-772
179. Sardanelli F, Quarenghi M (2006) MR spectroscopy of the heart. Radiol Med 111:1025-1034
180. Ingwall JS, Kramer MF, Fifer MA et al (1985) The creatine kinase system in normal and diseased human myocardium. N Engl J Med 313:1050-1054
181. Bessman SP, Geiger PJ (1981) Transport of energy in muscle: the phosphorylcreatine shuttle. Science 211:448-452
182. Perseghin G, De Cobelli F, Esposito A et al (2007) Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: a magnetic resonance imaging and phosphorus 31 spectroscopy study. Am Heart J 154:937-942
183. Pluim BM, Lamb HJ, Kayser HW et al (1998) Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation 97:666-672
184. Lamb HJ, Beyerbacht HP, van der Laarse A et al (1999) Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation 99:2261-2267
185. Esposito A, De Cobelli F, Perseghin G et al (2009) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228-233
186. Crilley JG, Boehm EA, Blair E (2003) Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 41:1776-1782
187. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G (1990) Regional myocardial metabolism of highenergy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 323:1593-600
188. Buchthal SD, den Hollander JA, Merz CN et al (2000) Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 342:829-835
189. Johnson BD, Shaw LJ, Buchthal SD et al; National Institutes of Health-National Heart, Lung, and Blood Institute (2004) Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109:2993-2999
190. Neubauer S (2007) The failing heart - an engine out of fuel. N Engl J Med 356:1140-1151
191. Beer M, Seyfarth T, Sandstede J et al (2002) Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40:1267-1274
192. Neubauer S, Horn M, Cramer M et al (1997) Myocardial phosphocreatineto- ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96:2190-2196
193. Fragasso G, Perseghin G, De Cobelli F et al (2006) Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 27:942-948
194. Scheuermann-Freestone M, Madsen PL, Manners D et al (2003) Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 107:3040-3046
195. Perseghin G, Fiorina P, De Cobelli F et al (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085-1092
196. Hudsmith LE, Neubauer S (2009) Magnetic resonance spectroscopy in myocardial disease. JACC Cardiovasc Imaging 2:87-96